Failure to validate existing clinical prediction scale for response to PD-1 monotherapy in advanced melanoma in national cohort study.

Find Full text
Thumbnail
Fulltext:
290913.pdf
Embargo:
until further notice
Size:
389.6Kb
Format:
PDF
Description:
Publisher’s version
Publication year
2023
Author(s)
Kooij, M.K. van der
Joosse, A.
Suijkerbuijk, K.P.
Aarts, M.J.
Berkmortel, F.W.P.J. van den
Blank, C.U.
Boers-Sonderen, M.J.
Eertwegh, A.J. van den
Groot, J.W.B. de
Haanen, J.B.A.G.
Hospers, G.A.
Piersma, D.
Rijn, R.S. van
Veldt, A.A.M. van der
Vreugdenhil, G.
Westgeest, H.M.
Wouters, M.W.
Dekkers, O.M.
Kapiteijn, E.
Source
British Journal of Cancer, 128, 5, (2023), pp. 707-710
ISSN
DOI
Publication type
Article / Letter to editor
Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/290913   https://hdl.handle.net/2066/290913
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.